Modelling suggests that the Lassa virus could infect millions in a decade, but vaccines under development could sharply ...

Researchers from Thomas Jefferson University and the University of Maryland Baltimore, in collaboration with the United ...

Researchers developed the LASSARAB vaccine, using a deactivated rabies virus to protect against Lassa fever. In preclinical ...

A promising Lassa fever vaccine shows potential to prevent severe disease and death in animals.

Blog - In global health, past epidemics are important learning experiences that shape our responses to future health emergencies. The 2014 Ebola epidemic in West Africa serves as a stark reminder of ...

Lassa fever is a deadly viral hemorrhagic illness that lowers the platelet count in the blood and its ability to clot, ...

The virus is on a priority watchlist from the WHO (World Health Organization) as it has the potential to cause a deadly ...

Nigeria is at the forefront of the Lassa fever crisis in West Africa, with a recent study revealing that the country bears over 50% of the West Africa’s cases of 2.7 million.

The first-ever detailed estimate of the real damage done by Lassa fever, a virus endemic to West Africa, has found that it infects 2.7 million people a year, ten times more than health agencies had ...

The deployment of a safe and effective Lassa vaccine across 15 nations in  West Africa might save 3,300 lives and up to $128 ...

Unfortunately, investment, research and development are in favour of the developed countries and it is recently that African ...

To date, several Lassa candidate vaccines are currently in development. However, out of these, Matthias Schnell, PhD, director of the Jefferson Center for Vaccines and Pandemic Preparedness at Thomas ...